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Case report
Ms.  K.,  a  37-year-old  patient,  consulted  the  emergency  ward  for  abdominal  pain  predomi-
nantly  in  the  hypochondrium  and  right  iliac  fossa.  This  patient  presented  a  past  history  of
anal  sphincter  plasty  for  incontinence  following  a  traumatic  childbirth.  The  clinical  exam-
ination  found  a  fever  at  38.8 ◦C  and  diffuse  abdominal  pain.  The  lab  tests  upon  admission
detected  an  inﬂammatory  syndrome  (leukocytes:  18,000/mm3 and  CRP:  150  mg/l)  without
cytolysis  or  cholestasis.  The  urine  strip  was  negative.  In  view  of  the  intensity  of  the  pain,  an
abdominal-pelvic  CT-scan  with  injection  was  carried  out  (Fig.  1)  to  search  for  acute  appen-
dicitis  or  acute  cholecystitis.  Acute  cholecystitis  was  diagnosed  in  view  of  the  distension
and  vesicular  parietal  thickening.  By  chance,  a  tumour  of  the  tip  of  the  cauda  pancreatis
was  discovered  and  a complementary  assessment  by  MRI  was  carried  out  (Fig.  2).
DOI of original article:http://dx.doi.org/10.1016/j.diii.2013.04.004.
 Here is the answer to the case ‘‘Caudal pancreatic tumor in a young patient’’ previously published. As a reminder we publish again the
entire case with the response following.
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Figure 1. Abdominal-pelvic CT in axial sections: a: axial section in spontaneous contrast; b: axial section injected at portal time.
Figure 2. Pancreatic MRI in axial sections: a: sequence T2; b: sequence T1 after fat saturation; c: sequence T1 EG dynamic after injection
at arterial time; d: sequence T1 EG dynamic after injection at portal time.
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of  the  exocrine  pancreas)  that  presents  a  low  potential  ofSolid  pseudopapillary  neoplasm  of  the  pancreas  
What is your diagnosis?
After  reading  the  case  report,  what  diagnosis  would  you
choose  from  the  following  proposals:
• mucinous  cystadenoma;
• pancreatoblastoma;
• neuroendocrine  pancreatic  tumour;
• solid  pseudopapillary  neoplasm  of  the  pancreas;
• mucinous  cystadenocarcinoma.
Diagnosis
Solid  pseudopapillary  neoplasm  of  the  pancreas.
Comments
The  injected  abdominal-pelvic  CT-scan  (Fig.  3a  and  b)
reveals  a  well-deﬁned  tumoral  mass  developed  at  the
expense  of  the  cauda  pancreatis.  This  oblong  lesion  meas-
ures  44  ×  30  mm  and  presents  a  punctiform  calciﬁcation
with  spontaneous  contrast  (Fig.  3a).  The  enhancement
is  heterogeneous  associating  progressive  enhancement  of
the  tissue  components  and  more  hypodense,  non-enhanced
areas  corresponding  to  cystic  zones.  The  pancreatic  MRI
(Fig.  4a—d)  detected  this  tumoral  mass  of  the  cauda  pan-
creatis,  measuring  4  ×  3  cm  in  the  transverse  plane.  This
lesion  presents  a  heterogeneous  T2  hypersignal  (Fig.  4a),
a  global  T1  hyposignal  with  the  presence  of  two  spots
in  spontaneous  hypersignal  of  haemorrhagic  appearance
(Fig.  4b).  The  enhancement  is  heterogeneous,  gradual  and
more  marked  late  (Fig.  4c  and  d).  There  are  cystic  zones
of  necrotic  appearance.  There  is  no  peripheral  capsule.  In
view  of  these  characteristics  and  considering  the  sex  and
age  of  our  patient,  a  solid  pseudopapillary  neoplasm  was
diagnosed.
The  diagnosis  of  mucinous  cystadenoma  is  eliminated
in  view  of  the  presence  of  an  enhanced  tissue  component
Figure 3. Abdominal-pelvic CT in axial sections: a: axial section in sp
with a central punctiform calciﬁcation (arrow); b: axial section in porta
area in the periphery (tip of arrow).
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nd  a heterogeneous  signal  on  sequences  T1  and  T2.  The
ifferential  diagnosis  with  mucinous  cystadenocarcinoma  is
ifﬁcult.  It  generally  consists  of  an  aggressive  tumour  that
nvades  the  pancreatic  parenchyma  while  the  solid  pseu-
opapillary  neoplasm  pushes  back  the  adjacent  structures.
n  addition,  the  mucinous  cystadenocarcinoma  does  not  gen-
rally  present  intra-lesional  haemorrhagic  reorganisation.  A
ancreatoblastoma  is  an  extremely  rare  malignant  tumour
nd  is  speciﬁcally  paediatric.  Jaundice  and  dilation  of  the
ile  ducts  are  very  often  associated.  The  diagnosis  of  neu-
oendocrine  tumour  of  the  pancreas  is  eliminated  in  view  of
he  absence  of  a  greatly  enhanced  shell  around  the  lesion.
The  patient  beneﬁted  from  a  cholecystectomy  and  a  cau-
al  pancreatectomy  by  coelioscopy  with  sacriﬁce  of  the
plenic  vessels  without  splenectomy.  The  extemporaneous
natomo-pathological  analysis  conﬁrmed  the  diagnosis  and
evealed  healthy  surgical  margins.  On  D2  after  the  opera-
ion,  a  CT-scan  was  carried  out  in  view  of  the  appearance
f  fever  associated  with  epigastric  pain  and  left  hypochon-
rium.  The  CT-scan  revealed  inﬁltration  of  the  pancreatic
egion  and  splenic  infarction  of  about  15%  of  the  volume  of
he  parenchyma.  The  symptoms  quickly  disappeared  and  no
ther  post-surgical  complications  were  noted.  The  diagno-
is  of  solid  pseudopapillary  neoplasm  of  the  pancreas  was
eﬁnitively  conﬁrmed  by  the  histology  and  immunohisto-
hemistry.
iscussion
ormerly  known  by  different  names:  Frantz  tumour,  solid
nd  cystic  epithelial  neoplasm  of  the  pancreas,  papillary
nd  cystic  neoplasm  of  the  pancreas,  in  1996,  the  WHO
enamed  this  lesion  solid  pseudopapillary  neoplasm  of  the
ancreas  [1].  This  is  a  rare  tumour  (about  1%  of  tumoursontaneous contrast: well-deﬁned tumour of the cauda pancreatic
l time: heterogeneous lesion enhancement with hypodense cystic
alignity  and  can  beneﬁt  from  surgical  treatment  [2].  This
umour  occurs  mainly  in  young  (mean  age:  24  years)  women
90%)  [3].  Clinically,  more  than  50%  of  the  cases  involve  an
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symptomatic  tumour  that  is  discovered  by  chance  [2].
he  most  common  symptoms  are  abdominal  pain,  nausea
nd  vomiting,  loss  of  weight  and  a  heavy  sensation  or
eight  on  the  stomach  [2,3].  More  rarely,  it’s  possible  to
bserve  intestinal  occlusion,  anaemia,  jaundice,  pancreati-
is,  an  obstruction  of  the  bile  ducts  or  a  traumatic  rupture
ith  haemoperitoneum  [2].  In  the  child,  the  most  common
ymptom  is  a  palpable  abdominal  mass  with  a  signiﬁcantly
igher  tumour  size  (8  cm  versus  6  cm  in  the  adult)  [2]. In
en,  the  mean  age  of  the  diagnosis  is  signiﬁcantly  higher
37  years  versus  26  years  in  women)  [3].  There  is  no  differ-
nce  between  the  sexes  as  regards  the  size  of  the  tumour,
he  clinical  symptoms,  the  imaging  characteristics  and  the
ocation  of  the  tumour  [3].
In  the  present  case,  it  was  discovered  by  chance  during
n  exploration  carried  out  for  an  acute  abdominal  syndrome
ith  acute  cholecystitis.
Histologically,  macroscopically,  the  lesion  is  separated
rom  the  healthy  parenchyma  by  a  thin  ﬁbrous  capsule.
icroscopically,  the  cystic  zones  are  surrounded  by  solid
umoral  tissue  presenting  characteristic  pseudopapillary
tructures  (Fig.  5a—c).  With  the  progression  of  the  tumour,
s
p
r
igure 4. Pancreatic MRI revealing a caudal pancreatic tumour: a: in
ith punctiform centro-lesional haemorrhagic hypersignals (arrows); c, d
evealing, at arterial time (c) peripheral enhancement late (d) a tendencyT.  Klotz  et  al.
ecrotic  and  haemorrhagic  zones  develop.  The  incidence  of
 malignant  transformation  of  these  tumours  is  about  15%
nd  occurs  either  by  local  invasion  or  by  metastatic  exten-
ion  at  a  distance  [2].
On  the  immunohistochemical  level,  the  tumoral  cells
xpress  a  great  many  immunomarkers  at  their  sur-
ace,  both  those  of  exocrine  tumours  (1-antitrypsin,
1-antichemotrypsin.  .  .) as  well  as  those  of  endocrine
ancreatic  tumours  (neurone-speciﬁc  enolase  and  synap-
ophysine).  A  recent  hypothesis  mentions  that  solid
seudopapillary  neoplasms  arise  from  undifferentiated  mul-
ipotent  stem  cells  [2].
In  the  imaging,  the  sonogram  may  reveal  a  well-deﬁned,
ounded,  oblong  or  polylobate,  encapsulated,  heteroge-
eous  mass  with  an  echogenic  tissue  component  and  an
nechogenic  cystic  component.  It  may  reveal  peripheral  cal-
iﬁcations  and  posterior  reinforcement.  A  mass  effect  may
xist  on  the  adjacent  structures  [2].  In  the  CT-scan,  the
ass  appears  to  be  heterogeneous  and  hypodense.  It  is  pos-ible  to  search  for  calciﬁcations.  After  injection,  there  is  a
eripheral  capsular  enhancement.  The  limits  of  the  CT-scan
emain  the  lack  of  tissue  resolution  [2].  The  pancreatic  MRI
 hypersignal in T2 weighting with fat saturation; b: hyposignal T1
: the EG T1 VIBE sequences after dynamic injection of gadolinium
 for homogenisation of the enhancement of the tissue components.
Solid  pseudopapillary  neoplasm  of  the  pancreas  1173
Figure 5. Pathological anatomy: a: macroscopy: solid well-deﬁned nodular lesion presenting cystic components with haemorrhagic
content; b: photomicrography (hematoxyline-eosine-safran × 12): revealing a heterogeneous, partially encapsulated tumour, presenting
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dcell areas and cystic zones with haemorrhagic content; c: photomic
structures (asterisk).
is  currently  the  choice  non-invasive  diagnostic  tool  for  cystic
masses  of  the  pancreas.  The  MRI  reveals  the  cystic  compo-
nents,  the  intra-lesional  haemorrhagic  rearrangements  and
the  presence  of  a  capsule,  in  the  form  of  a  hypodense
halo  on  weighted  T2  sequences,  characteristic  of  solid  pseu-
dopapillary  neoplasms  of  the  pancreas  [4,5].  In  addition,  the
lesion  is  generally  well-deﬁned,  voluminous,  of  mixed  tissue
and  cystic  content,  the  origin  of  a  heterogeneous  signal  in
hyper  or  hyposignal  T1  and  a  heterogeneous  signal  rather
in  hypersignal  T2  [4].  Nevertheless,  it  should  be  noted  that
the  concept  of  hypersignal  T1  in  the  cystic  zones,  classi-
cally  attributed  to  haemorrhagic  phenomena,  is  only  the
expression  of  an  increase  in  the  protein  concentration  that
is  not  synonymous  with  the  heme  of  haemoglobin,  a  myx-
oid  transformation  that  may  provide  the  same  images.  After
the  injection  of  Gadolinium,  there  is  peripheral  enhance-
ment  with  progressive  and  heterogeneous  lesion  ﬁlling  [1,4].
The  preferential  location  is  the  cauda  pancreatis.  The  lesion
pushes  back  the  adjacent  structures  without  invading  them
[2].  Canal  dilation  upstream  may  be  present  [2,6].  The  pres-
ence  of  these  signs  in  imaging  indicates  the  diagnosis  in  a
young  woman  since  80%  of  all  solid  pseudopapillary  neo-
plasm  of  the  pancreas  present  typical  characteristics  in
d
cphy (hematoxyline-eosine-safran × 100) revealing pseudopapillary
maging  (TDM  and/or  MRI)  [3].  Recent  studies  have  shown
hat  over  50%  of  the  lesions  were  diagnosed  before  surgery
2].
The  problem  of  the  differential  diagnosis  is  above  all
aised  with  neuroendocrine  tumours  of  the  pancreas  and
ucinous  cystadenocarcinomas  where  the  prognosis  is  less
avourable  [1]. The  cystic  forms  of  neuroendocrine  tumours
resent  a  localised  or  circumferential  hypervascular  thick-
ning  of  the  wall  after  injection  [5].  They  affect  older  adults
mean  age:  53  years),  without  preference  as  to  sex,  often  in
 context  of  multiple  endocrine  neoplasma  [1].  The  presence
f  enhanced  tissue  elements  associated  with  cystic  lesions
s  a  criterion  in  favour  of  mucinous  cystadenocarcinoma  [1].
n  the  child,  pancreatoblastoma  is  also  a  differential  diagno-
is.  This  is  an  extremely  rare  malignant  tumour,  sometimes
ontaining  cystic  zones  [7].  The  diagnosis  with  certainty  is
ased  on  the  histology.  All  of  these  differential  diagnoses
re  an  indication  for  surgical  treatment.  It  is  therefore  use-
ess  to  carry  out  a  puncture-biopsy  as  this  may  favour  cell
issemination,  the  cause  of  a  local  recurrence  of  metastatic
iffusion  [8].
Surgical  treatment  provides  a  cure  in  over  95%  of  the
ases  with  full  resection  and  microscopically  healthy  mar-
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ins.  As  for  tumours  of  the  body  of  the  pancreas  or
auda  pancreatis,  the  most  common,  a  distal  pancreatec-
omy  with  preservation  of  the  spleen  is  recommended.  For
umours  of  the  head  of  the  pancreas,  a  cephalic  duodeno-
ancreatectomy  with  preservation  of  the  pylorus  may  be
arried  out.  For  tumours  of  the  isthmus,  a  central  pan-
reatectomy  with  pancreaticojeujunal  or  pancreaticogastric
nastomosis  is  recommended.  For  small  tumours,  far  from
he  main  pancreatic  duct,  tumour  enucleation  may  be
onsidered.  Lymphadenectomy  is  not  recommended  since
ymph  node  metastases  are  extremely  rare.  In  a  study  on
92  patients,  Mao  et  al.  found  that  only  ﬁve  (2%)  of  the
atients  presented  lymph  node  invasion  [9].  This  data  is  con-
rmed  by  more  recent  studies  that  do  not  note  any  lymph
ode  metastasis  in  all  of  the  patients  included  [3,10]. The
urgical  resection  syndrome  of  metastases  is  justiﬁed  by
he  excellent  long-term  prognosis  even  in  the  presence  of
econdary  locations  [2].  In  men,  the  tumour  is  more  aggres-
ive  with  a  higher  incidence  of  invasion  of  the  portal  vein
hat  requires  more  radical  and  less  conservative  surgical
esection  [3].  Globally,  the  rate  of  morbidity  remains  close
o  60%  with,  in  particular,  the  occurrence  of  post-surgical
ancreatic  ﬁstulae,  infectious  complications  and  intestinal
cclusion  [3].
The  place  of  adjuvant  or  neo-adjuvant  treatments  has
ot  been  deﬁned.  The  rate  of  recurrence  is  estimated  at
etween  10  and  15%  after  resection  over  a  mean  follow-up
eriod  of  about  7  years.  It  is  therefore  necessary  to  monitor
hese  patients  over  a  relative  long  period  of  time  [2]. In
en,  close  and  prolonged  monitoring  is  recommended  [3].
he  rate  of  mortality  is  estimated  at  2%  [3].
onclusion
n  conclusion,  solid  pseudopapillary  neoplasms  of  the  pan-
reas  mainly  affect  young  women.  Abdominal  pain  is  the
ost  common  symptom  although  the  chance  discovery  by
maging  accounts  for  over  half  of  all  cases.  Due  to  the
xcellent  tissue  resolution,  the  pancreatic  MRI  is  the  best
maging  tool  to  characterise  cystic  tumours  of  the  pancreas.
he  diagnosis  of  solid  pseudopapillary  neoplasm  of  the  pan-
reas  will  be  based  on  the  MRI  in  view  of  the  presence  of
n  encapsulated  tissue  lesion  comprising  cystic  zones  and
ntra-tumoral  haemorrhagic  rearrangement.  It  is  a  tumour
[T.  Klotz  et  al.
ith  a  low  malignancy  potential,  a  good  prognosis  after  sur-
ical  treatment  although  it  requires  monitoring  due  to  the
otential  recurrence.
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